InsidersTradesSigma
Track the Biogen Pharmachem stock price and the full insider trade history of the company, a listed equity based in India. Shares are quoted on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €358m. The latest transaction was disclosed on 27 May 2026 (Disposal). Among the most active insiders: Interface Financial Services Ltd. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Biogen Pharmachem is a company specializing in the manufacturing of pharmaceutical and chemical products. It operates in the XBOM market.